Chembio Diagnostics Inc Quick Ratio (CEMI) starting from the fourth quarter 2022 to fourth quarter 2021, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Chembio Diagnostics Inc   (NASDAQ: CEMI)

Chembio Diagnostics Inc 's Quick Ratio

CEMI's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the fourth quarter 2022, Quick Ratio fell to 0.46 below Chembio Diagnostics Inc average.

Within Major Pharmaceutical Preparations industry 468 other companies have achieved higher Quick Ratio than Chembio Diagnostics Inc in fourth quarter 2022. While Quick Ratio total ranking has improved so far during the Q4 2022 to 2630, from total ranking in the third quarter 2022 at 2930.

Explain Quick Ratio?
How much Cash & cash equivalents CEMI´s has?
What are CEMI´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CEMI Quick Ratio (Dec 31 2022)
Q4		 (Sep 30 2022)
Q3		 (Jun 30 2022)
Q2		 (Mar 31 2022)
Q1		 (Dec 31 2021)
Q4
Y / Y Current Liabilities Change 107.88 % 238.03 % 48.82 % 44.49 % 53.06 %
Y / Y Cash & cash equivalent Change -36.82 % -41.52 % 310.42 % 70.02 % 24.74 %
Quick Ratio MRQ 0.46 0.55 1.63 1.79 1.52
CEMI's Total Ranking # 2630 # 2930 # 2596 # 1640 # 670
Seq. Current Liabilities Change 1.75 % 175.28 % 2.93 % -27.89 % 65.45 %
Seq. Cash & cash equivalent Change -13.66 % -7.8 % -6.4 % -15.2 % -20.08 %



Quick Ratio fourth quarter 2022 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 469
Healthcare Sector # 880
Overall Market # 2630


Quick Ratio Statistics
High Average Low
4 1.57 0.24
(Sep 30 2016)   (Sep 30 2015)




Financial Statements
Chembio Diagnostics Inc 's Current Liabilities $ 39 Millions Visit CEMI's Balance sheet
Chembio Diagnostics Inc 's Cash & cash equivalent $ 18 Millions Visit CEMI's Balance sheet
Source of CEMI's Sales Visit CEMI's Sales by Geography


Cumulative Chembio Diagnostics Inc 's Quick Ratio

CEMI's Quick Ratio for the trailling 12 Months

CEMI Quick Ratio

 (Dec 31 2022)
12 Months		 (Sep 30 2022)
12 Months		 (Jun 30 2022)
12 Months		 (Mar 31 2022)
12 Months		 (Dec 31 2021)
12 Months
Y / Y Current Liabilities TTM Growth 114.63 % 99.79 % 36.76 % 12.94 % 7.3 %
Y / Y Cash & cash equivalent TTM Growth 2.1 % 22.89 % 56.29 % -7.6 % -14.81 %
Quick Ratio TTM 0.82 1.14 1.93 1.77 1.72
Total Ranking TTM # 4759 # 4718 # 4654 # 4656 # 4645
Seq. Current Liabilities TTM Growth 23.94 % 46.9 % 8.62 % 8.53 % 15.37 %
Seq. Cash & cash equivalent TTM Growth -10.91 % -13.35 % 18.23 % 11.86 % 7.22 %

Quick ratio ranking by company, industry and sector >> Back to CEMI Financial Strength Comparisons >> Go to Compare CEMI Quick Ratio to its Competitors

On the trailing twelve months basis Due to rise in Current Liabilities in the Q4 2022 to $39.30 millions, cumulative Quick Ratio decreased to 0.82 below the Chembio Diagnostics Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 594 other companies have achieved higher Quick Ratio than Chembio Diagnostics Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2022 from 4718 to 4759.

Explain Quick Ratio?
How much Cash & cash equivalents CEMI´s has?
What are CEMI´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 595
Healthcare Sector # 1200
Within the Market # 4759


trailing twelve months Quick Ratio Statistics
High Average Low
2.51 1.62 0.51
(Jun 30 2020)   (Sep. 30, 2015)




Companies with similar Quick Ratio in the quarter ending Dec 31 2022, within Major Pharmaceutical Preparations Industry Quick RatioDec 31 2022 MRQ Cash & cash equivalentDec 31 2022 MRQ Current Liabilities
Stablecoin Development Corporation  1.26 $ 5.362  Millions$ 4.257  Millions
Wave Life Sciences Ltd   1.24 $ 88.497  Millions$ 71.521  Millions
Cytomx Therapeutics Inc   1.23 $ 193.650  Millions$ 157.795  Millions
Evotec Se  1.23 $ 525.926  Millions$ 428.630  Millions
Alkermes Plc   1.22 $ 608.465  Millions$ 497.742  Millions
Rockwell Medical inc   1.21 $ 21.492  Millions$ 17.691  Millions
Celyad Oncology Sa  1.19 $ 13.938  Millions$ 11.677  Millions
Ascendis Pharma A  1.16 $ 499.128  Millions$ 428.975  Millions
Evolus Inc   1.16 $ 53.922  Millions$ 46.509  Millions
Kineta Inc   1.14 $ 13.143  Millions$ 11.487  Millions
Transcode Therapeutics Inc   1.14 $ 4.968  Millions$ 4.347  Millions
Quantum Biopharma Ltd   1.14 $ 16.980  Millions$ 14.939  Millions
Myovant Sciences Ltd   1.12 $ 274.437  Millions$ 245.753  Millions
Sellas Life Sciences Group Inc   1.11 $ 17.225  Millions$ 15.515  Millions
Nanobiotix S a   1.09 $ 46.355  Millions$ 42.488  Millions
Prophase Labs Inc   1.08 $ 17.437  Millions$ 16.075  Millions
Molecular Templates Inc   1.07 $ 61.049  Millions$ 57.082  Millions
Puma Biotechnology Inc   1.05 $ 81.074  Millions$ 77.484  Millions
Dar Bioscience Inc   1.02 $ 34.670  Millions$ 33.940  Millions
Ptc Therapeutics inc   1.01 $ 410.705  Millions$ 406.236  Millions
Biolinerx Ltd   0.99 $ 10.587  Millions$ 10.679  Millions
Cti Biopharma Corp   0.99 $ 79.939  Millions$ 81.134  Millions
Kuvatris Therapeutics Inc   0.98 $ 1.902  Millions$ 1.935  Millions
Gyre Therapeutics Inc   0.97 $ 25.175  Millions$ 25.894  Millions
Pfizer Inc  0.96 $ 43,460.000  Millions$ 45,045.000  Millions
Xencor Inc  0.95 $ 60.890  Millions$ 63.844  Millions
Promis Neurosciences inc   0.92 $ 5.907  Millions$ 6.413  Millions
Paratek Pharmaceuticals Inc   0.92 $ 34.248  Millions$ 37.388  Millions
Nature s Sunshine Products inc   0.92 $ 60.032  Millions$ 65.582  Millions
Applied Therapeutics Inc   0.91 $ 30.580  Millions$ 33.424  Millions

Date modified: 2026-09-08T15:10:53+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.